logo

Menlo Therapeutics, Inc. (MNLO)



Trade MNLO now with
  Date
  Headline
10/8/2018 8:12:47 AM Menlo Therapeutics: Serlopitant Fails To Demonstrate Efficacy Relative To Placebo On Primary And Secondary Endpoints
9/17/2018 8:33:35 AM Menlo Therapeutics Begins European Prurigo Nodularis Phase 3 Trial And Presents Addl Data From PN Phase 2 Trial At EADV
5/7/2018 8:38:55 AM Menlo Therapeutics Announces Realignment Of Roles; Paul Kwon To Become Chief Scientific Officer
3/28/2018 4:15:49 PM Menlo Therapeutics Q4 Loss/share $1.80 Vs. Loss $0.96 Year Ago